Home/ALZpath/Jacob Hunter
JH

Jacob Hunter

Chief Business Officer

ALZpath

Therapeutic Areas

ALZpath Pipeline

DrugIndicationPhase
pTau217 AntibodyAlzheimer's disease detectionIVD